Literature DB >> 32892268

Lower Incidence of Postoperative Pulmonary Complications Following Robot-Assisted Minimally Invasive Esophagectomy for Esophageal Cancer: Propensity Score-Matched Comparison to Conventional Minimally Invasive Esophagectomy.

Shigeru Tsunoda1, Kazutaka Obama2, Shigeo Hisamori2, Tatsuto Nishigori2,3, Ryosuke Okamura2, Hisatsugu Maekawa2, Yoshiharu Sakai2.   

Abstract

BACKGROUND: Whether robot-assisted minimally invasive surgery (RAMIE) is more beneficial than conventional minimally invasive surgery (MIE) remains unclear.
METHODS: In total, 165 consecutive patients with esophageal carcinoma who underwent esophagectomy between January 2015 and April 2020 were retrospectively assessed. A 1:1 propensity score matching analysis was performed to compare the short-term outcomes between RAMIE and conventional MIE.
RESULTS: After matching, 45 patients were included in the RAMIE and conventional MIE groups. RAMIE had a significantly longer total operative time (708 vs. 612 min, P < 0.001) and thoracic operative time (348 vs. 285 min, P < 0.001) than conventional MIE. However, there were no significant differences in terms of oncological outcomes, such as R0 resection rate and number of resected lymph nodes. The overall postoperative morbidity (Clavien-Dindo [C-D] grade II or higher) rate of RAMIE and conventional MIE were 51% and 73% (P = 0.03), respectively, and the severe postoperative morbidity (C-D grade III or higher) rates were 11% and 29% (P = 0.04), respectively. The incidence rate of recurrent laryngeal nerve palsy was halved in RAMIE (7%) compared with conventional MIE (20%) (P = 0.06). Finally, the pulmonary complication rate (18%) was significantly lower in patients who underwent RAMIE than in those who underwent conventional MIE (44%) (P = 0.006).
CONCLUSIONS: RAMIE was safe and feasible, even during the early period of its application at a specialized center. Moreover, it may be a promising alternative to conventional MIE, with better short-term outcomes, including significantly lower incidence of pulmonary complications.

Entities:  

Mesh:

Year:  2020        PMID: 32892268     DOI: 10.1245/s10434-020-09081-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  30 in total

1.  Robot-assisted thoracoscopic esophagectomy with the patient in the prone position.

Authors:  Giovanni Dapri; Jacques Himpens; Guy-Bernard Cadière
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2006-06       Impact factor: 1.878

2.  Endoscopic oesophagectomy through a right thoracoscopic approach.

Authors:  A Cuschieri; S Shimi; S Banting
Journal:  J R Coll Surg Edinb       Date:  1992-02

3.  Advantages of the prone position for minimally invasive esophagectomy in comparison to the left decubitus position: better oxygenation after minimally invasive esophagectomy.

Authors:  Eiji Tanaka; Hiroshi Okabe; Yousuke Kinjo; Shigeru Tsunoda; Kazutaka Obama; Shigeo Hisamori; Yoshiharu Sakai
Journal:  Surg Today       Date:  2014-11-13       Impact factor: 2.549

4.  Mesenteric excision of upper esophagus: a concept for rational anatomical lymphadenectomy of the recurrent laryngeal nodes in thoracoscopic esophagectomy.

Authors:  Shigeru Tsunoda; Hisashi Shinohara; Seiichiro Kanaya; Hiroshi Okabe; Eiji Tanaka; Kazutaka Obama; Hisahiro Hosogi; Shigeo Hisamori; Yoshiharu Sakai
Journal:  Surg Endosc       Date:  2019-04-22       Impact factor: 4.584

5.  Does the Approach Matter? Comparing Survival in Robotic, Minimally Invasive, and Open Esophagectomies.

Authors:  Fernando Espinoza-Mercado; Taryne A Imai; Jerald D Borgella; Ariella Sarkissian; Derek Serna-Gallegos; Rodrigo F Alban; Harmik J Soukiasian
Journal:  Ann Thorac Surg       Date:  2018-10-09       Impact factor: 4.330

6.  Robot-assisted endoscopic surgery: a four-year single-center experience.

Authors:  Jelle P Ruurda; Werner A Draaisma; Richard van Hillegersberg; Inne H M Borel Rinkes; Hein G Gooszen; Lucas W M Janssen; Rogier K J Simmermacher; Ivo A M J Broeders
Journal:  Dig Surg       Date:  2005-09-28       Impact factor: 2.588

7.  First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer.

Authors:  R van Hillegersberg; J Boone; W A Draaisma; I A M J Broeders; M J M M Giezeman; I H M Borel Rinkes
Journal:  Surg Endosc       Date:  2006-05-15       Impact factor: 4.584

8.  First experiences with the da Vinci operating robot in thoracic surgery.

Authors:  J Bodner; H Wykypiel; G Wetscher; T Schmid
Journal:  Eur J Cardiothorac Surg       Date:  2004-05       Impact factor: 4.191

9.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

10.  Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2.

Authors:  Yuko Kitagawa; Takashi Uno; Tsuneo Oyama; Ken Kato; Hiroyuki Kato; Hirofumi Kawakubo; Osamu Kawamura; Motoyasu Kusano; Hiroyuki Kuwano; Hiroya Takeuchi; Yasushi Toh; Yuichiro Doki; Yoshio Naomoto; Kenji Nemoto; Eisuke Booka; Hisahiro Matsubara; Tatsuya Miyazaki; Manabu Muto; Akio Yanagisawa; Masahiro Yoshida
Journal:  Esophagus       Date:  2018-08-31       Impact factor: 3.671

View more
  9 in total

1.  ASO Author Reflections: Clinical Benefit of Robot-Assisted Minimally Invasive Esophagectomy over Conventional Minimally Invasive Esophagectomy.

Authors:  Shigeru Tsunoda; Kazutaka Obama
Journal:  Ann Surg Oncol       Date:  2020-08-31       Impact factor: 5.344

Review 2.  Why pay more for robot in esophageal cancer surgery?

Authors:  Fabrizio Rebecchi; Elettra Ugliono; Marco Ettore Allaix; Mario Morino
Journal:  Updates Surg       Date:  2022-08-11

Review 3.  Current status of robot-assisted minimally invasive esophagectomy: what is the real benefit?

Authors:  Jun Kanamori; Masayuki Watanabe; Suguru Maruyama; Yasukazu Kanie; Daisuke Fujiwara; Kei Sakamoto; Akihiko Okamura; Yu Imamura
Journal:  Surg Today       Date:  2021-12-01       Impact factor: 2.540

4.  Robotic-assisted minimally invasive Ivor Lewis esophagectomy within the prospective multicenter German da Vinci Xi registry trial.

Authors:  Jan-Hendrik Egberts; Thilo Welsch; Felix Merboth; Sandra Korn; Christian Praetorius; Daniel E Stange; Marius Distler; Matthias Biebl; Johann Pratschke; Felix Nickel; Beat Müller-Stich; Daniel Perez; Jakob R Izbicki; Thomas Becker; Jürgen Weitz
Journal:  Langenbecks Arch Surg       Date:  2022-05-02       Impact factor: 2.895

5.  McKeown esophagectomy with concomitant median arcuate ligament release in a case of esophageal cancer with celiac artery stenosis.

Authors:  Keita Hanada; Shigeru Tsunoda; Satoshi Ogiso; Tatsuto Nishigori; Shigeo Hisamori; Kazutaka Obama
Journal:  Surg Case Rep       Date:  2022-01-07

Review 6.  Peri-operative approach to esophagectomy: a narrative review from the anesthesiological standpoint.

Authors:  Cristian Deana; Luigi Vetrugno; Elena Bignami; Flavio Bassi
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 3.005

7.  Nursing Intervention Countermeasures of Robot-Assisted Laparoscopic Urological Surgery Complications.

Authors:  Xushu An; Jinyuan Zhou; Xuenan Ma; Bingbing Song
Journal:  Contrast Media Mol Imaging       Date:  2021-11-30       Impact factor: 3.161

8.  Robotic-Assisted Esophagectomy Leads to Significant Reduction in Postoperative Acute Pain: A Retrospective Clinical Trial.

Authors:  Jens P Hoelzen; Karl J Sander; Matteo Sesia; Dhruvajyoti Roy; Emile Rijcken; Alexander Schnabel; Benjamin Struecker; Mazen A Juratli; Andreas Pascher
Journal:  Ann Surg Oncol       Date:  2022-07-19       Impact factor: 4.339

9.  Transcervical inflatable mediastinoscopic esophagectomy versus thoracoscopic esophagectomy for local early- and intermediate-stage esophageal squamous cell carcinoma: A propensity score-matched analysis.

Authors:  Zihao Chen; Kenan Huang; Rongqiang Wei; Chengdong Liu; Yunhao Fang; Bin Wu; Zhifei Xu; Xinyu Ding; Hua Tang
Journal:  J Surg Oncol       Date:  2022-01-23       Impact factor: 2.885

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.